Chemed Corporation $CHE Shares Acquired by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd increased its position in shares of Chemed Corporation (NYSE:CHE) by 28.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,966 shares of the company’s stock after buying an additional 1,540 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Chemed were worth $2,631,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Keybank National Association OH grew its holdings in Chemed by 8.2% during the 1st quarter. Keybank National Association OH now owns 1,371 shares of the company’s stock worth $518,000 after acquiring an additional 104 shares in the last quarter. Mitchell & Pahl Private Wealth LLC raised its holdings in shares of Chemed by 10.3% in the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 1,590 shares of the company’s stock valued at $601,000 after purchasing an additional 148 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its position in shares of Chemed by 20.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 62,264 shares of the company’s stock worth $23,520,000 after purchasing an additional 10,498 shares during the last quarter. Pictet Asset Management Holding SA grew its stake in shares of Chemed by 5.0% during the first quarter. Pictet Asset Management Holding SA now owns 2,305 shares of the company’s stock worth $871,000 after purchasing an additional 110 shares in the last quarter. Finally, MBE Wealth Management LLC grew its stake in shares of Chemed by 11.2% during the first quarter. MBE Wealth Management LLC now owns 687 shares of the company’s stock worth $259,000 after purchasing an additional 69 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on CHE. Wall Street Zen cut Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Royal Bank Of Canada increased their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Two equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $501.50.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares of the company’s stock, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 3.33% of the company’s stock.

Chemed Price Performance

Shares of CHE opened at $485.48 on Wednesday. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $492.30. The stock has a market cap of $6.44 billion, a PE ratio of 26.46, a price-to-earnings-growth ratio of 1.77 and a beta of 0.52. The firm has a fifty day moving average price of $439.37 and a 200 day moving average price of $427.55.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. During the same quarter last year, the company posted $5.63 earnings per share. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, sell-side analysts anticipate that Chemed Corporation will post 22.67 EPS for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is 13.08%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.